November 1, 2006Expert Review of Medical Devices
BioMatrix ® Biolimus A9 ® -eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease
Key result
The BioMatrix Biolimus A9-eluting coronary stent, utilizing a biodegradable polylactic acid polymer, has been shown in clinical studies to be well tolerated and effective for coronary artery disease.
Population
Patients with coronary artery disease
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports consideration of BioMatrix in CAD; leaves open need for randomized comparisons versus contemporary DES.
Structured PICO
P
Population
Patients with coronary artery disease
I
Intervention
BioMatrix Biolimus A9-eluting coronary stent with biodegradable polylactic acid polymer
The BioMatrix stent, utilizing a biodegradable polymer and Biolimus A9, represents a next-generation drug-eluting stent platform designed to reduce inflammation and late thrombosis.
Cite This Study
Grube et al. (2006) conducted a review in coronary artery disease. BioMatrix Biolimus A9-eluting coronary stent was evaluated. The BioMatrix Biolimus A9-eluting coronary stent, utilizing a biodegradable polylactic acid polymer, has been shown in clinical studies to be well tolerated and effective for coronary artery disease.